This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, The University of Manchester, St George's Hosptial Medical School. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 1,226 
2 out of 233 
1 out of 1 Years Active: 2013-2020
Title: Innovations by Kerry Jenkins in Psychiatric and Neurological Treatment
Introduction
Kerry Jenkins is a prolific inventor based in Cambridge, GB, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of six patents, Jenkins has focused his research on creating innovative compounds that address pressing psychiatric and neurological conditions. His work combines deep scientific knowledge with practical applications that aim to improve mental health treatments.
Latest Patents
Among his latest innovations, Jenkins has developed piperidine derivatives intended for the treatment or prevention of psychiatric and neurological conditions. The present invention outlines compounds of formula (I) and the corresponding pharmaceutically acceptable salts. These derivatives have been formulated for therapeutic use, providing new avenues for drug development. Furthermore, another patent details compounds of formula (I), also emphasizing their potential in therapy and the processes involved in their preparation.
Career Highlights
Kerry Jenkins's career has been marked by his association with prominent organizations, notably Takeda Pharmaceutical Company Limited and The University of Manchester. His experience in these institutions has provided him with a robust platform for his research initiatives. He has consistently contributed to the advancement of pharmaceutical sciences through innovative thinking and persistent experimentation.
Collaborations
Throughout his career, Jenkins has collaborated with several esteemed colleagues, including Anne Goldby and Natasha Kinsella. Their combined efforts have played a pivotal role in pushing the boundaries of research and development in the therapeutic landscape.
Conclusion
Kerry Jenkins stands out as a notable inventor whose work epitomizes the spirit of innovation in the medical field. His dedication to developing effective treatment options for psychiatric and neurological conditions underscores the importance of ongoing research and collaboration in advancing healthcare. With his patents, Jenkins continues to make significant strides in enhancing the quality of life for individuals affected by mental health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile